CORCEPT THERAPEUTICS INC - Common Stock (CORT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CORT on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
106M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
77.2M
Holdings value
$6.41B
% of all portfolios
0.011%
Grand Portfolio weight change
0%
Number of holders
420
Number of buys
204
Number of sells
-203
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CORCEPT THERAPEUTICS INC - Common Stock (CORT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 10.9% -13.8% $847M -$133M 11.5M -13.6% BlackRock, Inc. 30 Jun 2025
INGALLS & SNYDER LLC 7.8% $599M 8.17M INGALLS & SNYDER LLC 31 Dec 2024
BELANOFF JOSEPH K 6.3% $500M 6.82M Joseph K. Belanoff 31 Dec 2024

Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 77.2M $6.41B -$137M $83.11 420
2025 Q2 79M $5.79B -$256M $73.40 418
2025 Q1 82M $9.12B -$127M $114.22 408
2024 Q4 84.2M $4.24B -$207M $50.39 362
2024 Q3 88.4M $4.09B +$3.39M $46.28 316
2024 Q2 89.2M $2.9B -$129M $32.49 282
2024 Q1 93.6M $2.36B +$207M $25.19 283
2023 Q4 84.7M $2.75B +$61.8M $32.48 269
2023 Q3 83M $2.26B +$53.2M $27.25 244
2023 Q2 81.5M $1.81B -$129M $22.25 224
2023 Q1 87.3M $1.89B +$97M $21.66 231
2022 Q4 83.5M $1.7B -$86.3M $20.31 241
2022 Q3 87.1M $2.23B +$46.3M $25.64 225
2022 Q2 85.1M $2.02B +$98.9M $23.78 214
2022 Q1 81.4M $1.84B +$19.6M $22.52 214
2021 Q4 80.6M $1.59B -$8.21M $19.80 199
2021 Q3 80.9M $1.59B +$4.94M $19.68 193
2021 Q2 80.5M $1.77B -$27.1M $22.00 193
2021 Q1 81.6M $1.94B -$37.9M $23.79 205
2020 Q4 83.4M $2.18B -$130M $26.16 219
2020 Q3 89.2M $1.55B +$5.15M $17.40 215
2020 Q2 89.6M $1.51B +$28.3M $16.82 215
2020 Q1 88.3M $1.05B -$9.51M $11.89 198
2019 Q4 89.1M $1.08B +$45.5M $12.10 199
2019 Q3 85.1M $1.2B -$5.45M $14.13 190
2019 Q2 86.3M $962M -$5.85M $11.15 178
2019 Q1 87.5M $1.03B -$43.9M $11.74 202
2018 Q4 91M $1.22B +$16M $13.36 218
2018 Q3 89.6M $1.26B +$22.2M $14.02 201
2018 Q2 87.6M $1.38B -$4.9M $15.72 212
2018 Q1 87.9M $1.45B -$15.3M $16.45 210
2017 Q4 88.8M $1.6B +$259M $18.06 184
2017 Q3 74.1M $1.43B +$88.3M $19.30 188
2017 Q2 69.8M $824M +$109M $11.80 155
2017 Q1 60.7M $665M +$151M $10.96 133
2016 Q4 53.3M $387M +$44.1M $7.26 135
2016 Q3 47.2M $307M +$9.89M $6.50 110
2016 Q2 45.7M $250M +$64.9M $5.46 109
2016 Q1 33.9M $159M -$1.37M $4.68 95
2015 Q4 34.2M $170M -$231K $4.98 95
2015 Q3 34.3M $129M +$5.43M $3.76 94
2015 Q2 32.5M $195M +$11.6M $6.01 78
2015 Q1 30.3M $170M +$9.78M $5.60 60
2014 Q4 28.8M $86.3M -$1.43M $3.00 50
2014 Q3 29.3M $78.6M -$1.07M $2.68 53
2014 Q2 29.7M $83.2M -$5.83M $2.80 61
2014 Q1 30.5M $133M +$10.5M $4.36 58